Denali Therapeutics amends bylaws for universal proxy and Delaware law updates

Denali Therapeutics Inc.

Board approved amended restated bylaws effective November 12, 2024.
Updates advance notice procedures for director nominations and stockholder proposals.
Requires stockholder to show Rule 14a-19 compliance 5 business days before meeting.
Conforms provisions to current Delaware General Corporation Law.
Updates provisions on directors, board committees, officers, and ministerial changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.